Search Results - "Okawa, Makoto"

Prospective Multicenter Screening With High-Sensitivity Cardiac Troponin T for Wild-Type Transthyretin Cardiac Amyloidosis in Outpatient and Community-Based Settings by Arima, Naoki, Ochi, Yuri, Kubo, Toru, Murakami, Yoshinori, Nishino, Kiyoshi, Yamamoto, Hironori, Satou, Koji, Tamura, Shinjiro, Okawa, Makoto, Takata, Hiroshi, Shimizu, Yuji, Baba, Yuichi, Yamasaki, Naohito, Kitaoka, Hiroaki

“…Background: High-sensitivity cardiac troponin T (hs-cTnT) was proposed as a simple and useful diagnostic tool for cardiac amyloidosis (CA). We performed…”
Get full text

Clinical Impact of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy: Results From Kochi RYOMA Study by Kubo, Toru, Kitaoka, Hiroaki, Okawa, Makoto, Hirota, Takayoshi, Hayato, Kayo, Yamasaki, Naohito, Matsumura, Yoshihisa, Yabe, Toshikazu, Takata, Jun, Doi, Yoshinori L.

“…Background: There have been few studies of the clinical features of hypertrophic cardiomyopathy (HCM) in a community-based patient cohort in Japan. Methods and…”
Get full text

Gender-specific differences in the clinical features of hypertrophic cardiomyopathy in a community-based Japanese population: Results from Kochi RYOMA study by Kubo, Toru, MD, Kitaoka, Hiroaki, MD, FJCC, Okawa, Makoto, MD, Hirota, Takayoshi, MD, Hayato, Kayo, MD, Yamasaki, Naohito, MD, Matsumura, Yoshihisa, MD, FJCC, Yabe, Toshikazu, MD, Doi, Yoshinori L., MD, FJCC

“…Summary Objectives Hypertrophic cardiomyopathy (HCM) is a primary myocardial disorder with a broad spectrum of clinical features. Although gender may be one of…”
Get full text

Combined Measurements of Cardiac Troponin I and Brain Natriuretic Peptide Are Useful for Predicting Adverse Outcomes in Hypertrophic Cardiomyopathy by Kubo, Toru, Kitaoka, Hiroaki, Okawa, Makoto, Yamanaka, Shigeo, Hirota, Takayoshi, Baba, Yuichi, Hayato, Kayo, Yamasaki, Naohito, Matsumura, Yoshihisa, Yasuda, Nobufumi, Sugiura, Tetsuro, Doi, Yoshinori L.

“…Background: Although serum cardiac troponin I (cTnI) and plasma brain natriuretic peptide (BNP) have become clinically important tools as diagnostic and…”
Get full text

Effect of Left Ventricular Reverse Remodeling on Long-Term Prognosis After Therapy With Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers and β Blockers in Patients With Idiopathic Dilated Cardiomyopathy by Hoshikawa, Eri, MD, Matsumura, Yoshihisa, MD, PhD, Kubo, Toru, MD, PhD, Okawa, Makoto, MD, PhD, Yamasaki, Naohito, MD, PhD, Kitaoka, Hiroaki, MD, PhD, Furuno, Takashi, MD, Takata, Jun, MD, PhD, Doi, Yoshinori L., MD, PhD

“…It remains unknown whether left ventricular (LV) reverse remodeling (LVRR) after therapy with angiotensin-converting enzyme inhibitors or angiotensin II…”
Get full text

Tissue Doppler Imaging and Plasma BNP Levels to Assess the Prognosis in Patients with Hypertrophic Cardiomyopathy by Kitaoka, Hiroaki, MD, Kubo, Toru, MD, Okawa, Makoto, MD, Takenaka, Nana, MD, Sakamoto, Chiyo, MD, Baba, Yuichi, MD, Hayashi, Kayo, MD, Yamasaki, Naohito, MD, Matsumura, Yoshihisa, MD, Doi, Yoshinori L., MD

“…Background In addition to sudden death, heart failure and stroke due to atrial fibrillation are important in patients with hypertrophic cardiomyopathy (HCM)…”
Get full text

Usefulness of High-Sensitive Cardiac Troponin T for Evaluating the Activity of Cardiac Sarcoidosis by Baba, Yuichi, Kubo, Toru, Kitaoka, Hiroaki, Okawa, Makoto, Yamanaka, Shigeo, Kawada, Yasumasa, Yamasaki, Naohito, Matsumura, Yoshihisa, Furuno, Takashi, Sugiura, Tetsuro, Doi, Yoshinori L.

“…Since early intervention using corticosteroids improves prognosis in some patients with cardiac sarcoidosis, early and accurate diagnosis of this clinical…”
Get full text

Clinical Profiles of Hypertrophic Cardiomyopathy With Apical Phenotype: Comparison of Pure-Apical Form and Distal-Dominant Form by Kubo, Toru, Kitaoka, Hiroaki, Okawa, Makoto, Hirota, Takayoshi, Hoshikawa, Eri, Hayato, Kayo, Yamasaki, Naohito, Matsumura, Yoshihisa, Yabe, Toshikazu, Nishinaga, Masanori, Takata, Jun, Doi, Yoshinori L.

“…Background: Hypertrophic cardiomyopathy (HCM) with an apical phenotype, in which hypertrophy of the myocardium predominantly involves the apex of the left…”
Get full text

Lifelong Left Ventricular Remodeling of Hypertrophic Cardiomyopathy Caused by a Founder Frameshift Deletion Mutation in the Cardiac Myosin-Binding Protein C Gene Among Japanese by Kubo, Toru, Kitaoka, Hiroaki, Okawa, Makoto, Matsumura, Yoshihisa, Hitomi, Nobuhiko, Yamasaki, Naohito, Furuno, Takashi, Takata, Jun, Nishinaga, Masanori, Kimura, Akinori, Doi, Yoshinori L.

“…Lifelong Left Ventricular Remodeling of Hypertrophic Cardiomyopathy Caused by a Founder Frameshift Deletion Mutation in the Cardiac Myosin-Binding Protein C…”
Get full text

Genetic Screening and Double Mutation in Japanese Patients With Hypertrophic Cardiomyopathy by Kubo, Toru, Kitaoka, Hiroaki, Okawa, Makoto, Baba, Yuichi, Hirota, Takayoshi, Hayato, Kayo, Yamasaki, Naohito, Matsumura, Yoshihisa, Otsuka, Haruna, Arimura, Takuro, Kimura, Akinori, Doi, Yoshinori L.

“…Background: Hypertrophic cardiomyopathy (HCM) is a primary myocardial disorder with an autosomal-dominant pattern of inheritance mainly caused by single…”
Get full text

Impact of Metalloproteinases on Left Ventricular Remodeling and Heart Failure Events in Patients With Hypertrophic Cardiomyopathy by Kitaoka, Hiroaki, Kubo, Toru, Okawa, Makoto, Hayato, Kayo, Yamasaki, Naohito, Matsumura, Yoshihisa, Doi, Yoshinori L.

“…Background: The impact of matrix metalloproteinase (MMP) on left ventricular (LV) remodeling and heart failure events is unresolved in patients with…”
Get full text

Serum Cardiac Troponin I is Related to Increased Left Ventricular Wall Thickness, Left Ventricular Dysfunction, and Male Gender in Hypertrophic Cardiomyopathy by Kubo, Toru, Kitaoka, Hiroaki, Okawa, Makoto, Yamanaka, Shigeo, Hirota, Takayoshi, Hoshikawa, Eri, Hayato, Kayo, Yamasaki, Naohito, Matsumura, Yoshihisa, Yasuda, Nobufumi, Sugiura, Tetsuro, Doi, Yoshinori L.

“…Background Serum cardiac troponin I (cTnI) is a sensitive and specific marker of myocardial injury. However, a systematic evaluation of cTnI in hypertrophic…”
Get full text

Hypertrophic cardiomyopathy in the elderly by Kubo, Toru, Kitaoka, Hiroaki, Okawa, Makoto, Nishinaga, Masanori, Doi, Yoshinori L

“…Hypertrophic cardiomyopathy (HCM) is a relatively common genetic cardiac disorder with heterogeneous morphological, functional and clinical features. Although…”
Get full text

Plasma metalloproteinase levels and left ventricular remodeling in hypertrophic cardiomyopathy in patients with an identical mutation by Kitaoka, Hiroaki, MD, Kubo, Toru, MD, Okawa, Makoto, MD, Takenaka, Nana, MD, Baba, Yuichi, MD, Yamasaki, Naohito, MD, Matsumura, Yoshihisa, MD, Furuno, Takashi, MD, Doi, Yoshinori L., MD

“…Summary Background and purpose Although it has been reported that matrix metalloproteinases (MMPs) are associated with left ventricular (LV) remodeling in…”
Get full text

A novel cardiac myosin-binding protein C S297X mutation in hypertrophic cardiomyopathy by Hirota, Takayoshi, MD, Kubo, Toru, MD, Kitaoka, Hiroaki, MD, FJCC, Hamada, Tomoyuki, MD, Baba, Yuichi, MD, Hayato, Kayo, MD, Okawa, Makoto, MD, Yamasaki, Naohito, MD, Matsumura, Yoshihisa, MD, FJCC, Yabe, Toshikazu, MD, Doi, Yoshinori L., MD, FJCC

“…Summary Background Mutations in the cardiac myosin-binding protein C gene ( MYBPC3 ) have been reported to be associated with delayed expression of…”
Get full text

Inflammatory Abdominal Aortic Aneurysm Successfully Treated With Steroid Therapy by Yabe, Toshikazu, MD, Hamada, Tomoyuki, MD, Kubo, Toru, MD, Okawa, Makoto, MD, Yamasaki, Naohito, MD, Matsumura, Yoshihisa, MD, Kitaoka, Hiroaki, MD, Doi, Yoshinori, MD

“…A computed tomography scan showed a 4.0-cm infrarenal abdominal aortic aneurysm (A) with extremely thickened aortic wall and surrounding soft tissue mass (B)…”
Get full text

A frameshift deletion mutation in the cardiac myosin-binding protein C gene associated with dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy by Hitomi, Nobuhiko, MD, Kubo, Toru, MD, Kitaoka, Hiroaki, MD, FJCC, Hirota, Takayoshi, MD, Hamada, Tomoyuki, MD, Hoshikawa, Eri, MD, Hayato, Kayo, MD, Okawa, Makoto, MD, Kimura, Akinori, MD, Doi, Yoshinori L., MD, FJCC

“…Summary Objectives A few studies reported that some mutations in the cardiac myosin-binding protein C (MyBPC) gene were associated with dilated phase of…”
Get full text

Hemolytic anemia in a patient with hypertrophic obstructive cardiomyopathy by Kubo, Toru, MD, Kitaoka, Hiroaki, MD, FJCC, Terauchi, Yasunobu, MD, Tamura, Shinjiro, MD, Okawa, Makoto, MD, Yamasaki, Naohito, MD, Yabe, Toshikazu, MD, Doi, Yoshinori L., MD, FJCC

“…Summary A 66-year-old woman was referred for further evaluation and treatment of normocytic and normochromic anemia with hemoglobin level of 8.6 g/dL. A…”
Get full text

Left Ventricular Remodeling of Hypertrophic Cardiomyopathy: Longitudinal Observation in a Rural Community by Kitaoka, Hiroaki, Kubo, Toru, Okawa, Makoto, Hitomi, Nobuhiko, Furuno, Takashi, Doi, Yoshinori L

“…Background The purpose of the present study was to assess the clinical long-term course of hypertrophic cardiomyopathy (HCM) in a rural Japanese cohort…”
Get full text

Long-Term Prognosis of Dilated Cardiomyopathy Revisited: An Improvement in Survival Over the Past 20 Years by Matsumura, Yoshihisa, Takata, Jun, Kitaoka, Hiroaki, Kubo, Toru, Baba, Yuichi, Hoshikawa, Eri, Hamada, Tomoyuki, Okawa, Makoto, Hitomi, Nobuhiko, Sato, Kyoko, Yamasaki, Naohito, Yabe, Toshikazu, Furuno, Takashi, Nishinaga, Masanori, Doi, Yoshinori

“…Background Because of their favorable prognostic effects, angiotensin converting enzyme inhibitors (ACEI), angiotensin II receptor blockers (ARB) and β…”
Get full text